Halozyme Announces Preclinical Data Presentations At The Association Of Cancer Research Annual Meeting
April 08, 2014 at 09:05 AM EDT
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that two scientific poster presentations on the pharmacology of PEGPH20 will ...